Details of the Drug Combinations

General Information of This Drug (ID: DMTJAEP)

Drug Name
Vinflunine   DMTJAEP
Synonyms Javlor (TN)
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

615 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
10-hydroxycamptothecin + Vinflunine DC1MZTG 10-hydroxycamptothecin Colon carcinoma (Cell Line: KM12) [2]
10-hydroxycamptothecin + Vinflunine DC2RJZ5 10-hydroxycamptothecin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
ABIRATERONE + Vinflunine DC7X3W0 ABIRATERONE Anaplastic large cell lymphoma (Cell Line: SR) [4]
ABIRATERONE + Vinflunine DCT9L6D ABIRATERONE Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
ABIRATERONE + Vinflunine DC8N3X4 ABIRATERONE Glioma (Cell Line: SF-539) [4]
ABIRATERONE + Vinflunine DC2J084 ABIRATERONE Plasma cell myeloma (Cell Line: RPMI-8226) [4]
ABIRATERONE + Vinflunine DC3KPRQ ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [4]
ABIRATERONE + Vinflunine DCY37RG ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [4]
ABIRATERONE + Vinflunine DCLS1BG ABIRATERONE Carcinoma (Cell Line: MCF7) [2]
ABIRATERONE + Vinflunine DCYC3JI ABIRATERONE Colon carcinoma (Cell Line: KM12) [2]
ABIRATERONE + Vinflunine DCR6EP8 ABIRATERONE Adenocarcinoma (Cell Line: OVCAR3) [3]
ABIRATERONE + Vinflunine DCTYQ2D ABIRATERONE Adenocarcinoma (Cell Line: NCIH23) [3]
ABIRATERONE + Vinflunine DCTG0NG ABIRATERONE Adenocarcinoma (Cell Line: HCT-15) [3]
ABIRATERONE + Vinflunine DCR8ASR ABIRATERONE Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
ABIRATERONE + Vinflunine DCRDCYK ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Amonafide + Vinflunine DC5U0PX Amonafide Adenocarcinoma (Cell Line: HCT-15) [4]
Amonafide + Vinflunine DCNFACN Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Amonafide + Vinflunine DCVMZH2 Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Amonafide + Vinflunine DC0YH00 Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [4]
Amonafide + Vinflunine DC22S8F Amonafide Astrocytoma (Cell Line: U251) [4]
Amonafide + Vinflunine DCB9O8K Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Amonafide + Vinflunine DCSPR9B Amonafide Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Amonafide + Vinflunine DCRE1YA Amonafide Carcinoma (Cell Line: MCF7) [2]
Amonafide + Vinflunine DCIG1BM Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Anastrozole + Vinflunine DCDP90O Anastrozole Adenocarcinoma (Cell Line: HCT-15) [4]
Anastrozole + Vinflunine DCJBSUM Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Anastrozole + Vinflunine DCM6V34 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [4]
Anastrozole + Vinflunine DC0SDLW Anastrozole Renal cell carcinoma (Cell Line: UO-31) [4]
Anastrozole + Vinflunine DC0XG9P Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Azacitidine + Vinflunine DCG68F4 Azacitidine Adenocarcinoma (Cell Line: HCT-15) [4]
Azacitidine + Vinflunine DCRV4OI Azacitidine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Azacitidine + Vinflunine DC46502 Azacitidine Astrocytoma (Cell Line: U251) [4]
Azacitidine + Vinflunine DCDA1JV Azacitidine Chronic myelogenous leukemia (Cell Line: K-562) [4]
Azacitidine + Vinflunine DCVL3D4 Azacitidine Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Azacitidine + Vinflunine DCHR2OQ Azacitidine Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Azacitidine + Vinflunine DCMD2S9 Azacitidine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Azacitidine + Vinflunine DCD4DBT Azacitidine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Azacitidine + Vinflunine DCQOUAG Azacitidine Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Azacitidine + Vinflunine DC7F132 Azacitidine Colon carcinoma (Cell Line: KM12) [2]
Azacitidine + Vinflunine DC2RXT1 Azacitidine Invasive ductal carcinoma (Cell Line: HS 578T) [2]
BIO-300 + Vinflunine DCINVKA BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [4]
BIO-300 + Vinflunine DCW4QSJ BIO-300 Astrocytoma (Cell Line: SNB-19) [4]
BIO-300 + Vinflunine DC1DGTQ BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
BIO-300 + Vinflunine DCZGARG BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [4]
BIO-300 + Vinflunine DCM5X09 BIO-300 Glioblastoma (Cell Line: SNB-75) [4]
BIO-300 + Vinflunine DCE2RTA BIO-300 Glioma (Cell Line: SF-295) [4]
BIO-300 + Vinflunine DCS57CK BIO-300 Glioma (Cell Line: SF-539) [4]
BIO-300 + Vinflunine DCB8VR3 BIO-300 Carcinoma (Cell Line: MCF7) [2]
BIO-300 + Vinflunine DCAJO7H BIO-300 Adenocarcinoma (Cell Line: HCT-15) [3]
BIO-300 + Vinflunine DCFPX4H BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
BIO-300 + Vinflunine DC4W9SH BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Bleomycin + Vinflunine DC7BIU0 Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Bleomycin + Vinflunine DCDMSX2 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Bleomycin + Vinflunine DCCODKO Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [4]
Bleomycin + Vinflunine DCAVH70 Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [4]
Bleomycin + Vinflunine DC7K67Y Bleomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Bleomycin + Vinflunine DCRMEPZ Bleomycin Glioma (Cell Line: SF-295) [4]
Bleomycin + Vinflunine DC664XC Bleomycin Glioma (Cell Line: SF-539) [4]
Bleomycin + Vinflunine DC9P0DT Bleomycin Carcinoma (Cell Line: MCF7) [2]
Bleomycin + Vinflunine DCIENGO Bleomycin Adenocarcinoma (Cell Line: A549) [3]
Bleomycin + Vinflunine DCOSJG5 Bleomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Bleomycin + Vinflunine DCGNC1G Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Bleomycin + Vinflunine DCPIVY4 Bleomycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Cabazitaxel + Vinflunine DCJ5Z1K Cabazitaxel Adenocarcinoma (Cell Line: OVCAR3) [4]
Cabazitaxel + Vinflunine DCIZWS0 Cabazitaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Cabazitaxel + Vinflunine DC8XHIC Cabazitaxel Amelanotic melanoma (Cell Line: M14) [4]
Cabazitaxel + Vinflunine DC4H26Y Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Cabazitaxel + Vinflunine DC32MB5 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Cabazitaxel + Vinflunine DCJA90T Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Cabazitaxel + Vinflunine DCX39YP Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Cabazitaxel + Vinflunine DCT07QU Cabazitaxel Glioblastoma (Cell Line: SNB-75) [4]
Cabazitaxel + Vinflunine DC3YUB8 Cabazitaxel Glioma (Cell Line: SF-295) [4]
Cabazitaxel + Vinflunine DCHIAAZ Cabazitaxel Glioma (Cell Line: SF-539) [4]
Cabazitaxel + Vinflunine DCISXGO Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Cabazitaxel + Vinflunine DC1VTQ8 Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Cabazitaxel + Vinflunine DC9NVC6 Cabazitaxel Malignant melanoma (Cell Line: UACC62) [4]
Cabazitaxel + Vinflunine DCNJCTT Cabazitaxel Melanoma (Cell Line: SK-MEL-2) [4]
Cabazitaxel + Vinflunine DC39CLN Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Cabazitaxel + Vinflunine DCIO655 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [4]
Cabazitaxel + Vinflunine DCRFFYI Cabazitaxel Colon adenocarcinoma (Cell Line: COLO 205) [2]
Cabazitaxel + Vinflunine DCC5HLY Cabazitaxel Colon carcinoma (Cell Line: KM12) [2]
Cabazitaxel + Vinflunine DCRZUEE Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Crizotinib + Vinflunine DCNBGRL Crizotinib Adenocarcinoma (Cell Line: NCIH23) [4]
Crizotinib + Vinflunine DCCMSOQ Crizotinib Adenocarcinoma (Cell Line: HCT-15) [4]
Crizotinib + Vinflunine DC8UAYU Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Crizotinib + Vinflunine DC98O7V Crizotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Crizotinib + Vinflunine DCUVA90 Crizotinib Chronic myelogenous leukemia (Cell Line: K-562) [4]
Crizotinib + Vinflunine DCEKX6D Crizotinib Clear cell renal cell carcinoma (Cell Line: A498) [4]
Crizotinib + Vinflunine DC6302U Crizotinib Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Crizotinib + Vinflunine DCSNX5H Crizotinib Glioma (Cell Line: SF-295) [4]
Crizotinib + Vinflunine DCXXTJG Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Crizotinib + Vinflunine DCYVNOM Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Crizotinib + Vinflunine DCKVOKI Crizotinib Renal cell carcinoma (Cell Line: SN12C) [4]
Crizotinib + Vinflunine DCNPCUH Crizotinib Carcinoma (Cell Line: MCF7) [2]
Crizotinib + Vinflunine DCZG66G Crizotinib Colon carcinoma (Cell Line: KM12) [2]
Dacarbazine + Vinflunine DCHOMMW Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Dactinomycin + Vinflunine DCVPLNX Dactinomycin Carcinoma (Cell Line: MCF7) [2]
Dactinomycin + Vinflunine DCUBWRH Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Dactinomycin + Vinflunine DCX2KLW Dactinomycin Astrocytoma (Cell Line: U251) [3]
Dactinomycin + Vinflunine DCEL3SX Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dactinomycin + Vinflunine DCXZAHC Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Dactinomycin + Vinflunine DCN987D Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dasatinib + Vinflunine DCUIZLP Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Dasatinib + Vinflunine DC4M7CD Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Dasatinib + Vinflunine DCNWV78 Dasatinib Carcinoma (Cell Line: MCF7) [2]
Dexrazoxane + Vinflunine DCNZJN1 Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Dexrazoxane + Vinflunine DC6OOK0 Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Dexrazoxane + Vinflunine DCEDXDY Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [4]
Dexrazoxane + Vinflunine DCNWR2G Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Dexrazoxane + Vinflunine DC2ZA2O Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [2]
DFN-15 + Vinflunine DCUUQPO DFN-15 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
DFN-15 + Vinflunine DCG5YAD DFN-15 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
DFN-15 + Vinflunine DC98440 DFN-15 Chronic myelogenous leukemia (Cell Line: K-562) [4]
DFN-15 + Vinflunine DC1ZLKQ DFN-15 Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
DFN-15 + Vinflunine DC7NT7W DFN-15 Glioblastoma (Cell Line: SNB-75) [4]
DFN-15 + Vinflunine DCZ7IPY DFN-15 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
DFN-15 + Vinflunine DCYHMLY DFN-15 Invasive ductal carcinoma (Cell Line: HS 578T) [2]
DFN-15 + Vinflunine DCMQNBG DFN-15 Adenocarcinoma (Cell Line: OVCAR3) [3]
DFN-15 + Vinflunine DCGSSDF DFN-15 Adenocarcinoma (Cell Line: NCIH23) [3]
DFN-15 + Vinflunine DC7T3FR DFN-15 Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
DFN-15 + Vinflunine DCE0YDY DFN-15 Malignant melanoma (Cell Line: LOX IMVI) [3]
Digitoxin + Vinflunine DCF8C2P Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [4]
Digitoxin + Vinflunine DCEOJTX Digitoxin Astrocytoma (Cell Line: SNB-19) [4]
Digitoxin + Vinflunine DCMYCWC Digitoxin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Digitoxin + Vinflunine DCZQV2C Digitoxin Malignant melanoma (Cell Line: UACC62) [4]
Digitoxin + Vinflunine DCZDYKM Digitoxin Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Digitoxin + Vinflunine DCYAJUQ Digitoxin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Digitoxin + Vinflunine DCNC5Z0 Digitoxin Carcinoma (Cell Line: MCF7) [2]
Digitoxin + Vinflunine DCDW38J Digitoxin Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Epirubicin + Vinflunine DC19CJ0 Epirubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Epirubicin + Vinflunine DC2GSOI Epirubicin Glioblastoma (Cell Line: SNB-75) [4]
Epirubicin + Vinflunine DCB46RW Epirubicin Glioma (Cell Line: SF-539) [4]
Epirubicin + Vinflunine DCVNP7T Epirubicin Renal cell carcinoma (Cell Line: UO-31) [4]
Epirubicin + Vinflunine DCFSEOG Epirubicin Renal cell carcinoma (Cell Line: SN12C) [4]
Estramustine + Vinflunine DCU8NLB Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Estramustine + Vinflunine DCKVGBL Estramustine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Estramustine + Vinflunine DCCJBWK Estramustine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Fludarabine + Vinflunine DCHPRYJ Fludarabine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Fludarabine + Vinflunine DCCN7YT Fludarabine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Fludarabine + Vinflunine DCCU0KV Fludarabine Invasive ductal carcinoma (Cell Line: T-47D) [2]
Fludarabine + Vinflunine DC44LEP Fludarabine Lung adenocarcinoma (Cell Line: EKVX) [3]
Fludarabine + Vinflunine DCW2QYL Fludarabine Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Gefitinib + Vinflunine DCURV9U Gefitinib Adenocarcinoma (Cell Line: A549) [4]
Gefitinib + Vinflunine DCQ3UU0 Gefitinib Adenocarcinoma (Cell Line: HCT-15) [4]
Gefitinib + Vinflunine DCHWUK3 Gefitinib Adenocarcinoma (Cell Line: SW-620) [4]
Gefitinib + Vinflunine DCG45GL Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Gefitinib + Vinflunine DCG7N1H Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [4]
Gefitinib + Vinflunine DCYXOXJ Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [4]
Gefitinib + Vinflunine DCQC7IE Gefitinib Glioma (Cell Line: SF-268) [4]
Gefitinib + Vinflunine DCUB0C9 Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Gefitinib + Vinflunine DCMRXB6 Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [4]
Gefitinib + Vinflunine DC04003 Gefitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Gefitinib + Vinflunine DCDKD9W Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Gefitinib + Vinflunine DCD9NY3 Gefitinib Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Idarubicin + Vinflunine DCM0FX8 Idarubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Idarubicin + Vinflunine DCN316N Idarubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Idarubicin + Vinflunine DCCGHVM Idarubicin Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Idarubicin + Vinflunine DCTSK22 Idarubicin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Idarubicin + Vinflunine DCCGCBM Idarubicin Carcinoma (Cell Line: MCF7) [2]
Idarubicin + Vinflunine DCFB65P Idarubicin Invasive ductal carcinoma (Cell Line: T-47D) [2]
Idarubicin + Vinflunine DCFPNKR Idarubicin Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Idarubicin + Vinflunine DCISIAG Idarubicin Adenocarcinoma (Cell Line: OVCAR3) [3]
Idarubicin + Vinflunine DCEFXO1 Idarubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Idarubicin + Vinflunine DC62DA6 Idarubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Idarubicin + Vinflunine DCP1P3N Idarubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Idarubicin + Vinflunine DCNJV4A Idarubicin Prostate carcinoma (Cell Line: PC-3) [3]
Imatinib + Vinflunine DC0X5TT Imatinib Adenocarcinoma (Cell Line: OVCAR3) [4]
Imatinib + Vinflunine DCO0VCA Imatinib Adenocarcinoma (Cell Line: NCIH23) [4]
Imatinib + Vinflunine DC4ZITY Imatinib Adenocarcinoma (Cell Line: HT29) [4]
Imatinib + Vinflunine DC4YGAD Imatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Imatinib + Vinflunine DCJP1DG Imatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Imatinib + Vinflunine DCK7PAN Imatinib Astrocytoma (Cell Line: U251) [4]
Imatinib + Vinflunine DCE0TXJ Imatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Imatinib + Vinflunine DCZETHP Imatinib Clear cell renal cell carcinoma (Cell Line: A498) [4]
Imatinib + Vinflunine DCP8WFA Imatinib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Imatinib + Vinflunine DC7PBS1 Imatinib Glioblastoma (Cell Line: SNB-75) [4]
Imatinib + Vinflunine DCSI4ZI Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Imatinib + Vinflunine DCLO24B Imatinib Malignant melanoma (Cell Line: LOX IMVI) [4]
Imatinib + Vinflunine DCGL4GC Imatinib Malignant melanoma (Cell Line: UACC62) [4]
Imatinib + Vinflunine DC5XFOC Imatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Imatinib + Vinflunine DCXYLU7 Imatinib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Imatinib + Vinflunine DCNRFBN Imatinib Carcinoma (Cell Line: MCF7) [2]
Imatinib + Vinflunine DCYCXD6 Imatinib Colon carcinoma (Cell Line: KM12) [2]
Indazole derivative 5 + Vinflunine DCM44Q2 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Indazole derivative 5 + Vinflunine DCF5VPL Indazole derivative 5 Glioma (Cell Line: SF-539) [4]
Indazole derivative 5 + Vinflunine DCDRWS3 Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
JNK-IN-8 + Vinflunine DCUIH7W JNK-IN-8 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
JNK-IN-8 + Vinflunine DCC315T JNK-IN-8 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
JNK-IN-8 + Vinflunine DCF21IE JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Lapatinib + Vinflunine DCA5V4P Lapatinib Carcinoma (Cell Line: MCF7) [2]
Lapatinib + Vinflunine DCYP1TC Lapatinib Colon carcinoma (Cell Line: KM12) [2]
Lapatinib + Vinflunine DCZXFTC Lapatinib Invasive ductal carcinoma (Cell Line: T-47D) [2]
Lapatinib + Vinflunine DC4NCSD Lapatinib Invasive ductal carcinoma (Cell Line: BT-549) [2]
Lapatinib + Vinflunine DCN5X64 Lapatinib Adenocarcinoma (Cell Line: HCT-15) [3]
Lapatinib + Vinflunine DC6SDWH Lapatinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Lapatinib + Vinflunine DCHWWXX Lapatinib Astrocytoma (Cell Line: U251) [3]
Lapatinib + Vinflunine DCPQ4M8 Lapatinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Lapatinib + Vinflunine DCEXLU4 Lapatinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Lapatinib + Vinflunine DCST8LA Lapatinib Glioma (Cell Line: SF-539) [3]
Lapatinib + Vinflunine DCOCAX9 Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Lapatinib + Vinflunine DCDDUO0 Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Lapatinib + Vinflunine DCUS801 Lapatinib Malignant melanoma (Cell Line: UACC62) [3]
Lapatinib + Vinflunine DCW3415 Lapatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Lapatinib + Vinflunine DC8OTR9 Lapatinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Lenalidomide + Vinflunine DC0SEMO Lenalidomide Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Letrozole + Vinflunine DCJZBEL Letrozole Adenocarcinoma (Cell Line: OVCAR3) [4]
Letrozole + Vinflunine DCN8NO7 Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Letrozole + Vinflunine DCXMSQ6 Letrozole Colon carcinoma (Cell Line: KM12) [2]
LIAROZOLE + Vinflunine DCMY449 LIAROZOLE Papillary renal cell carcinoma (Cell Line: ACHN) [4]
LIAROZOLE + Vinflunine DC8JZ5R LIAROZOLE Adenocarcinoma (Cell Line: OVCAR3) [3]
LIAROZOLE + Vinflunine DCC10GK LIAROZOLE Adenocarcinoma (Cell Line: HCC-2998) [3]
Mechlorethamine + Vinflunine DC1XN3T Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Nilotinib + Vinflunine DCICEDA Nilotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Nilotinib + Vinflunine DCQMJ9P Nilotinib Chronic myelogenous leukemia (Cell Line: K-562) [4]
Nilotinib + Vinflunine DC43U6F Nilotinib Invasive ductal carcinoma (Cell Line: T-47D) [2]
Nilotinib + Vinflunine DCTL5ZN Nilotinib Adenocarcinoma (Cell Line: DU-145) [3]
Nilotinib + Vinflunine DCBYC8N Nilotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Nilotinib + Vinflunine DCU1BQ4 Nilotinib Adenocarcinoma (Cell Line: SW-620) [3]
Nilotinib + Vinflunine DC6QF9H Nilotinib Adenocarcinoma (Cell Line: HT29) [3]
Plicamycin + Vinflunine DCK7XUO Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Plicamycin + Vinflunine DCTVI56 Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Plicamycin + Vinflunine DC5QJYU Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [4]
Plicamycin + Vinflunine DCV44QE Plicamycin Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Plicamycin + Vinflunine DCF54TO Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Plicamycin + Vinflunine DCZSK1P Plicamycin Glioma (Cell Line: SF-268) [4]
Plicamycin + Vinflunine DCCPXCZ Plicamycin Glioma (Cell Line: SF-539) [4]
Plicamycin + Vinflunine DCTY2VI Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Plicamycin + Vinflunine DC8JR4M Plicamycin Renal cell carcinoma (Cell Line: SN12C) [4]
Plicamycin + Vinflunine DCGM0IW Plicamycin Carcinoma (Cell Line: MCF7) [2]
Plicamycin + Vinflunine DCVZHW0 Plicamycin Colon adenocarcinoma (Cell Line: COLO 205) [2]
Plicamycin + Vinflunine DC96ZF6 Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [2]
Plicamycin + Vinflunine DC8O2OL Plicamycin Adenocarcinoma (Cell Line: DU-145) [3]
Plicamycin + Vinflunine DC5PYG2 Plicamycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Plicamycin + Vinflunine DCDCUXO Plicamycin Adenocarcinoma (Cell Line: A549) [3]
Plicamycin + Vinflunine DC4JOQM Plicamycin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Plicamycin + Vinflunine DC8ZX2E Plicamycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Plicamycin + Vinflunine DCT4SIP Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Plicamycin + Vinflunine DC5G2SS Plicamycin Melanoma (Cell Line: SK-MEL-2) [3]
Plicamycin + Vinflunine DCOQLZV Plicamycin Melanoma (Cell Line: UACC-257) [3]
Plicamycin + Vinflunine DCY3LBW Plicamycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Plicamycin + Vinflunine DCV3CVY Plicamycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Plicamycin + Vinflunine DCXXO7N Plicamycin Prostate carcinoma (Cell Line: PC-3) [3]
PMID28460551-Compound-2 + Vinflunine DCBD2I2 PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
PMID28460551-Compound-2 + Vinflunine DCSJ6K4 PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [4]
PMID28460551-Compound-2 + Vinflunine DCQ7SRQ PMID28460551-Compound-2 Glioblastoma (Cell Line: SNB-75) [4]
PMID28460551-Compound-2 + Vinflunine DC97MWG PMID28460551-Compound-2 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
PMID28460551-Compound-2 + Vinflunine DCNQA6J PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [2]
PMID28460551-Compound-2 + Vinflunine DCZYW69 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DU-145) [3]
PMID28460551-Compound-2 + Vinflunine DCSAGMW PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH23) [3]
PMID28460551-Compound-2 + Vinflunine DC0D1H5 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCC-2998) [3]
PMID28460551-Compound-2 + Vinflunine DCRRMLZ PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Raloxifene + Vinflunine DCDGBKQ Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [4]
Raloxifene + Vinflunine DCMLH6X Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Raloxifene + Vinflunine DCQ0UOT Raloxifene Carcinoma (Cell Line: MCF7) [2]
Raloxifene + Vinflunine DC88PEB Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Raloxifene + Vinflunine DCZZVXS Raloxifene Adenocarcinoma (Cell Line: DU-145) [3]
Raloxifene + Vinflunine DCRRYLO Raloxifene Adenocarcinoma (Cell Line: OVCAR3) [3]
Raloxifene + Vinflunine DCMXXGM Raloxifene Adenocarcinoma (Cell Line: SW-620) [3]
Raloxifene + Vinflunine DC71EVC Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Raloxifene + Vinflunine DC6CVU3 Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Raloxifene + Vinflunine DCR43SK Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Romidepsin + Vinflunine DCMEUL1 Romidepsin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Romidepsin + Vinflunine DCX9XVC Romidepsin Renal cell carcinoma (Cell Line: UO-31) [4]
Ruxolitinib + Vinflunine DCK0KQ8 Ruxolitinib Clear cell renal cell carcinoma (Cell Line: A498) [4]
SCH 727965 + Vinflunine DCZMQQG SCH 727965 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
SCH 727965 + Vinflunine DCU1IQH SCH 727965 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
SCH 727965 + Vinflunine DCXRM9O SCH 727965 Chronic myelogenous leukemia (Cell Line: K-562) [4]
SCH 727965 + Vinflunine DCSPKNB SCH 727965 Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
SCH 727965 + Vinflunine DCN5DWM SCH 727965 Glioblastoma (Cell Line: SNB-75) [4]
SCH 727965 + Vinflunine DCR68GN SCH 727965 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
SCH 727965 + Vinflunine DC73KW6 SCH 727965 Carcinoma (Cell Line: MCF7) [2]
SCH 727965 + Vinflunine DC50RVI SCH 727965 Colon carcinoma (Cell Line: KM12) [2]
SCH 727965 + Vinflunine DCE0ZJ3 SCH 727965 Adenocarcinoma (Cell Line: OVCAR3) [3]
SCH 727965 + Vinflunine DCLBITW SCH 727965 Adenocarcinoma (Cell Line: HCC-2998) [3]
SCH 727965 + Vinflunine DCD3313 SCH 727965 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
SCH 727965 + Vinflunine DC9ISN2 SCH 727965 Lung adenocarcinoma (Cell Line: EKVX) [3]
Sirolimus + Vinflunine DCFLKBO Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Sirolimus + Vinflunine DCTCS9L Sirolimus Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Sirolimus + Vinflunine DCUD87H Sirolimus Carcinoma (Cell Line: MCF7) [2]
Sirolimus + Vinflunine DCF7R4C Sirolimus Adenocarcinoma (Cell Line: OVCAR3) [3]
Sirolimus + Vinflunine DCNDBSM Sirolimus Adenocarcinoma (Cell Line: HCT-15) [3]
Sirolimus + Vinflunine DC48FB0 Sirolimus Adenocarcinoma (Cell Line: SW-620) [3]
Sirolimus + Vinflunine DCNZR44 Sirolimus Lung adenocarcinoma (Cell Line: HOP-62) [3]
Sirolimus + Vinflunine DCIP2WD Sirolimus Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Sirolimus + Vinflunine DCQD0GW Sirolimus Malignant melanoma (Cell Line: UACC62) [3]
Sirolimus + Vinflunine DCYH1N4 Sirolimus Malignant melanoma (Cell Line: LOX IMVI) [3]
Sirolimus + Vinflunine DCLIY5K Sirolimus Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Sirolimus + Vinflunine DCQUQ8L Sirolimus Prostate carcinoma (Cell Line: PC-3) [3]
Sorafenib + Vinflunine DCOLMT8 Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Sorafenib + Vinflunine DCRAW0Y Sorafenib Clear cell renal cell carcinoma (Cell Line: A498) [4]
Sorafenib + Vinflunine DC4URY3 Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Sorafenib + Vinflunine DC5N3ZZ Sorafenib Glioma (Cell Line: SF-539) [4]
Sorafenib + Vinflunine DC33W85 Sorafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Sorafenib + Vinflunine DCQB30S Sorafenib Malignant melanoma (Cell Line: UACC62) [4]
Sorafenib + Vinflunine DCYC8QO Sorafenib Melanoma (Cell Line: UACC-257) [4]
Sorafenib + Vinflunine DCDA4D4 Sorafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Sorafenib + Vinflunine DCN1JC4 Sorafenib Invasive ductal carcinoma (Cell Line: HS 578T) [2]
SY-1425 + Vinflunine DCMXQGT SY-1425 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
SY-1425 + Vinflunine DCNMWLG SY-1425 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
SY-1425 + Vinflunine DC0ZOL9 SY-1425 Astrocytoma (Cell Line: U251) [4]
SY-1425 + Vinflunine DC475S3 SY-1425 Astrocytoma (Cell Line: SNB-19) [4]
SY-1425 + Vinflunine DCA69Z7 SY-1425 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
SY-1425 + Vinflunine DCIM8MA SY-1425 Chronic myelogenous leukemia (Cell Line: K-562) [4]
SY-1425 + Vinflunine DCKH99K SY-1425 Glioblastoma (Cell Line: SNB-75) [4]
SY-1425 + Vinflunine DCSXPKQ SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
SY-1425 + Vinflunine DCZ4DXJ SY-1425 Renal cell carcinoma (Cell Line: SN12C) [4]
SY-1425 + Vinflunine DC8N5UQ SY-1425 Carcinoma (Cell Line: MCF7) [2]
SY-1425 + Vinflunine DCGHHUF SY-1425 Colon carcinoma (Cell Line: KM12) [2]
SY-1425 + Vinflunine DCWKSPV SY-1425 Invasive ductal carcinoma (Cell Line: BT-549) [2]
SY-1425 + Vinflunine DC7IB28 SY-1425 Adenocarcinoma (Cell Line: OVCAR3) [3]
SY-1425 + Vinflunine DC5X5PH SY-1425 Adenocarcinoma (Cell Line: HT29) [3]
SY-1425 + Vinflunine DCGHP7R SY-1425 Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
SY-1425 + Vinflunine DCUJYGX SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
SY-1425 + Vinflunine DC934VJ SY-1425 Lung adenocarcinoma (Cell Line: HOP-62) [3]
SY-1425 + Vinflunine DC5FO64 SY-1425 Malignant melanoma (Cell Line: LOX IMVI) [3]
SY-1425 + Vinflunine DCED3UH SY-1425 Malignant melanoma (Cell Line: UACC62) [3]
SY-1425 + Vinflunine DCVQRWN SY-1425 Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
SY-1425 + Vinflunine DCE77KE SY-1425 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Taxol + Vinflunine DC02A62 Taxol Chronic myelogenous leukemia (Cell Line: K-562) [4]
Taxol + Vinflunine DC70TZC Taxol Invasive ductal carcinoma (Cell Line: BT-549) [2]
Taxol + Vinflunine DCIEOUT Taxol Adenocarcinoma (Cell Line: NCIH23) [3]
Taxol + Vinflunine DC8RK5R Taxol Adenocarcinoma (Cell Line: HCC-2998) [3]
Taxol + Vinflunine DC8JX0C Taxol Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Taxol + Vinflunine DCHVXR3 Taxol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Taxol + Vinflunine DCAB71M Taxol Lung adenocarcinoma (Cell Line: HOP-62) [3]
Taxol + Vinflunine DCRVG15 Taxol Malignant melanoma (Cell Line: UACC62) [3]
Taxol + Vinflunine DCN5H30 Taxol Malignant melanoma (Cell Line: LOX IMVI) [3]
Taxol + Vinflunine DCQZBRR Taxol Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Taxol + Vinflunine DCIZYXH Taxol Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Thioguanine + Vinflunine DC5TQAT Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [4]
Topotecan + Vinflunine DCSWPZC Topotecan Carcinoma (Cell Line: MCF7) [2]
Topotecan + Vinflunine DCUQ6GX Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Topotecan + Vinflunine DCQBY12 Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Topotecan + Vinflunine DCMMKFW Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Topotecan + Vinflunine DCV0J6X Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Topotecan + Vinflunine DCKQBK8 Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Triapine + Vinflunine DC1X7QR Triapine Carcinoma (Cell Line: MCF7) [2]
Triapine + Vinflunine DCDXQB0 Triapine Invasive ductal carcinoma (Cell Line: BT-549) [2]
Triapine + Vinflunine DCFR6A1 Triapine Astrocytoma (Cell Line: SNB-19) [3]
Triapine + Vinflunine DC6U48X Triapine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Triapine + Vinflunine DC117O9 Triapine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Triapine + Vinflunine DCVVWZX Triapine Glioma (Cell Line: SF-539) [3]
Triapine + Vinflunine DCDURCF Triapine Glioma (Cell Line: SF-295) [3]
Triapine + Vinflunine DCCCYMK Triapine Malignant melanoma (Cell Line: UACC62) [3]
Triapine + Vinflunine DCAQJ3P Triapine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Trifluridine + Vinflunine DCPCD6O Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Uracil mustard + Vinflunine DCUWWPU Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Uracil mustard + Vinflunine DCM83QA Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [4]
Uracil mustard + Vinflunine DCWDOI2 Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Uracil mustard + Vinflunine DC604FK Uracil mustard Glioblastoma (Cell Line: SNB-75) [4]
Uracil mustard + Vinflunine DCPV76R Uracil mustard Glioma (Cell Line: SF-295) [4]
Uracil mustard + Vinflunine DC7X7SD Uracil mustard Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Uracil mustard + Vinflunine DCE8ASK Uracil mustard Adenocarcinoma (Cell Line: DU-145) [3]
Uracil mustard + Vinflunine DCU32DV Uracil mustard Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vandetanib + Vinflunine DCH11IR Vandetanib Adenocarcinoma (Cell Line: DU-145) [3]
Vandetanib + Vinflunine DCXY22E Vandetanib Adenocarcinoma (Cell Line: OVCAR3) [3]
Vandetanib + Vinflunine DC0DTE7 Vandetanib Adenocarcinoma (Cell Line: NCIH23) [3]
Vandetanib + Vinflunine DCENWOT Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Vandetanib + Vinflunine DCCCZHC Vandetanib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Vandetanib + Vinflunine DCZH8MS Vandetanib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Vandetanib + Vinflunine DCYC4Z7 Vandetanib Glioma (Cell Line: SF-295) [3]
Vandetanib + Vinflunine DCPXXW7 Vandetanib Glioma (Cell Line: SF-539) [3]
Vandetanib + Vinflunine DCC8RNT Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [3]
Vandetanib + Vinflunine DC1KZWX Vandetanib Renal cell carcinoma (Cell Line: SN12C) [3]
Vemurafenib + Vinflunine DCX2Y5S Vemurafenib Adenocarcinoma (Cell Line: HCT-15) [3]
Vemurafenib + Vinflunine DC1TOTN Vemurafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Vemurafenib + Vinflunine DCF9QN6 Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Vemurafenib + Vinflunine DC7C2HB Vemurafenib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Vemurafenib + Vinflunine DCDI7NC Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Vemurafenib + Vinflunine DCM0MMJ Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vemurafenib + Vinflunine DC7XLUY Vemurafenib Glioma (Cell Line: SF-539) [3]
Vemurafenib + Vinflunine DCYXPH7 Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vemurafenib + Vinflunine DC2A6E2 Vemurafenib Malignant melanoma (Cell Line: UACC62) [3]
Vemurafenib + Vinflunine DC0KTCJ Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [3]
Vemurafenib + Vinflunine DCBIUDG Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vemurafenib + Vinflunine DC76O3L Vemurafenib Renal cell carcinoma (Cell Line: UO-31) [3]
Vincristine + Vinflunine DCXF21V Vincristine Adenocarcinoma (Cell Line: NCIH23) [4]
Vincristine + Vinflunine DCCRSV8 Vincristine Adenocarcinoma (Cell Line: HT29) [4]
Vincristine + Vinflunine DC4MVMM Vincristine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vincristine + Vinflunine DCDUCO8 Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vincristine + Vinflunine DCRPUT5 Vincristine Astrocytoma (Cell Line: U251) [4]
Vincristine + Vinflunine DCBNH10 Vincristine Glioma (Cell Line: SF-539) [4]
Vincristine + Vinflunine DCTLEGV Vincristine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Vincristine + Vinflunine DCJEA27 Vincristine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Vincristine + Vinflunine DCFOF9R Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vincristine + Vinflunine DCSSU4K Vincristine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Vincristine + Vinflunine DC0HUQV Vincristine Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Vinflunine + Pentostatin DCSDWSD Pentostatin Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vinflunine + Pentostatin DC63EUD Pentostatin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vinflunine + Pentostatin DCLB66M Pentostatin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + Pentostatin DCVUWRB Pentostatin Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Hepzato DCASY1N Hepzato Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Dactinomycin DCGJX9I Dactinomycin Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + PMID28460551-Compound-2 DCQVSAS PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vinflunine + PMID28460551-Compound-2 DCSVAID PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [4]
Vinflunine + PMID28460551-Compound-2 DC3TRQM PMID28460551-Compound-2 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + Cyclophosphamide DCBIOT5 Cyclophosphamide Glioma (Cell Line: SF-539) [4]
Vinflunine + Cyclophosphamide DC5R252 Cyclophosphamide Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Panobinostat DCJAK5T Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Vinflunine + Isoniazid DC4CDYW Isoniazid Glioma (Cell Line: SF-295) [4]
Vinflunine + Arsenic trioxide DCCQXZG Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Arsenic trioxide DCUUMKG Arsenic trioxide Astrocytoma (Cell Line: U251) [4]
Vinflunine + Arsenic trioxide DC9G9CN Arsenic trioxide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Vinflunine + Nilotinib DC92D6G Nilotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Nilotinib DC79JFP Nilotinib Astrocytoma (Cell Line: SNB-19) [4]
Vinflunine + Nilotinib DCVON59 Nilotinib Clear cell renal cell carcinoma (Cell Line: A498) [4]
Vinflunine + Nilotinib DCOCU4S Nilotinib Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Topetecan DC9FFUV Topetecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vinflunine + Topetecan DCTVW0K Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vinflunine + Ifosfamide DCVF7UE Ifosfamide Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Vinflunine + Docetaxel DC97B6D Docetaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Docetaxel DCID2BG Docetaxel Astrocytoma (Cell Line: U251) [4]
Vinflunine + Docetaxel DCC4ZAE Docetaxel Chronic myelogenous leukemia (Cell Line: K-562) [4]
Vinflunine + Docetaxel DCZ2GJO Docetaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vinflunine + Raloxifene DCCM1PW Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Raloxifene DC91W9S Raloxifene Clear cell renal cell carcinoma (Cell Line: A498) [4]
Vinflunine + Raloxifene DCDPAM9 Raloxifene Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Bendamustine hydrochloride DCB1X1F Bendamustine hydrochloride Clear cell renal cell carcinoma (Cell Line: A498) [4]
Vinflunine + Bendamustine hydrochloride DCE0WQ7 Bendamustine hydrochloride Glioma (Cell Line: SF-295) [4]
Vinflunine + Sirolimus DC7UC1R Sirolimus Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vinflunine + Sirolimus DCQ2VSX Sirolimus Astrocytoma (Cell Line: U251) [4]
Vinflunine + Sirolimus DCYQO7Q Sirolimus Clear cell renal cell carcinoma (Cell Line: A498) [4]
Vinflunine + Mitomycin DC4PHYL Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Mitomycin DCUDAMM Mitomycin Astrocytoma (Cell Line: SNB-19) [4]
Vinflunine + Mitomycin DCFNL5N Mitomycin Glioma (Cell Line: SF-539) [4]
Vinflunine + Mitomycin DC1XVYU Mitomycin Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Vinflunine + Mitomycin DCJ2BLH Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + Mitomycin DCQKIUZ Mitomycin Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Altretamine DCBBD0A Altretamine Glioma (Cell Line: SF-539) [4]
Vinflunine + Bortezomib DCLQ49N Bortezomib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Vinflunine + Cisplatin DCOF3ZI Cisplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Cisplatin DCF2FF2 Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vinflunine + Cisplatin DCA1FK7 Cisplatin Astrocytoma (Cell Line: U251) [4]
Vinflunine + Cisplatin DCV4A4A Cisplatin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + Chlorambucil DCEGQA4 Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vinflunine + ER819762 DCEAJHN ER819762 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Pomalidomide DCQY8BD Pomalidomide Astrocytoma (Cell Line: U251) [4]
Vinflunine + Pomalidomide DC6E56E Pomalidomide Glioma (Cell Line: SF-539) [4]
Vinflunine + Pomalidomide DC9ICHN Pomalidomide Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + Mercaptopurine DCODB6P Mercaptopurine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vinflunine + Mercaptopurine DC3L96A Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vinflunine + PMID28870136-Compound-43 DCXKN42 PMID28870136-Compound-43 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Vinflunine + PMID28870136-Compound-43 DCQGTFD PMID28870136-Compound-43 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vinflunine + PMID28870136-Compound-43 DC4AJUU PMID28870136-Compound-43 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + FORMESTANE DCIRC6E FORMESTANE Astrocytoma (Cell Line: U251) [4]
Vinflunine + FORMESTANE DCUSS8J FORMESTANE Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Vinflunine + FORMESTANE DC2KW6N FORMESTANE Glioma (Cell Line: SF-295) [4]
Vinflunine + Aminolevulinic Acid Hydrochloride DC6K1IF Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vinflunine + Aminolevulinic Acid Hydrochloride DCGGPX4 Aminolevulinic Acid Hydrochloride Astrocytoma (Cell Line: U251) [4]
Vinflunine + Busulfan DC2NGHB Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Busulfan DCFSTQT Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vinflunine + Busulfan DC6N1J7 Busulfan Astrocytoma (Cell Line: U251) [4]
Vinflunine + Busulfan DC6S3KI Busulfan Glioblastoma (Cell Line: SNB-75) [4]
Vinflunine + Busulfan DCPJBD0 Busulfan Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Fulvestrant DC2PV44 Fulvestrant Breast adenocarcinoma (Cell Line: MDA-MB-468) [2]
Vinflunine + Fulvestrant DCTZ2IN Fulvestrant Invasive ductal carcinoma (Cell Line: T-47D) [2]
Vinflunine + Hepzato DCFLQAD Hepzato Carcinoma (Cell Line: MCF7) [2]
Vinflunine + PMID28460551-Compound-2 DCN3YZN PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Vinflunine + Arsenic trioxide DC1933G Arsenic trioxide Invasive ductal carcinoma (Cell Line: BT-549) [2]
Vinflunine + Pralatrexate DCS4196 Pralatrexate Colon carcinoma (Cell Line: KM12) [2]
Vinflunine + Terameprocol DC0KM44 Terameprocol Colon adenocarcinoma (Cell Line: COLO 205) [2]
Vinflunine + Terameprocol DC7YALS Terameprocol Colon carcinoma (Cell Line: KM12) [2]
Vinflunine + Ifosfamide DCAXKLY Ifosfamide Breast adenocarcinoma (Cell Line: MDA-MB-468) [2]
Vinflunine + Docetaxel DCLQTCZ Docetaxel Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Vinflunine + Raloxifene DC8X7ZZ Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [2]
Vinflunine + Bendamustine hydrochloride DCI0JSG Bendamustine hydrochloride Colon adenocarcinoma (Cell Line: COLO 205) [2]
Vinflunine + Bendamustine hydrochloride DC57VSV Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: T-47D) [2]
Vinflunine + Mitomycin DCTUJMU Mitomycin Invasive ductal carcinoma (Cell Line: T-47D) [2]
Vinflunine + Altretamine DC2PO3G Altretamine Invasive ductal carcinoma (Cell Line: T-47D) [2]
Vinflunine + Valrubicin DC2QQXS Valrubicin Carcinoma (Cell Line: RXF 393) [2]
Vinflunine + Cisplatin DC9MEPD Cisplatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [2]
Vinflunine + Azacitidine DCW266T Azacitidine Colon adenocarcinoma (Cell Line: COLO 205) [2]
Vinflunine + Azacitidine DCNH903 Azacitidine Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Vinflunine + Pomalidomide DC59YGW Pomalidomide Breast adenocarcinoma (Cell Line: MDA-MB-468) [2]
Vinflunine + Pomalidomide DCB1WC5 Pomalidomide Invasive ductal carcinoma (Cell Line: T-47D) [2]
Vinflunine + Pomalidomide DCQTDWI Pomalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [2]
Vinflunine + PMID28870136-Compound-43 DCNH7OL PMID28870136-Compound-43 Carcinoma (Cell Line: RXF 393) [2]
Vinflunine + Aminolevulinic Acid Hydrochloride DCXI460 Aminolevulinic Acid Hydrochloride Breast adenocarcinoma (Cell Line: MDA-MB-468) [2]
Vinflunine + Busulfan DC2718J Busulfan Carcinoma (Cell Line: MCF7) [2]
Vinflunine + Busulfan DC4M7MG Busulfan Colon carcinoma (Cell Line: KM12) [2]
Vinflunine + Pentostatin DCEA5WP Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vinflunine + Pentostatin DCCSMQ8 Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + Pentostatin DCU4WVF Pentostatin Malignant melanoma (Cell Line: LOX IMVI) [3]
Vinflunine + Pentostatin DC35V15 Pentostatin Malignant melanoma (Cell Line: UACC62) [3]
Vinflunine + Pentostatin DCFTKAJ Pentostatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + Pentostatin DC6NQGY Pentostatin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinflunine + Fulvestrant DCKVVFE Fulvestrant Adenocarcinoma (Cell Line: A549) [3]
Vinflunine + Fulvestrant DCC6NEN Fulvestrant Adenocarcinoma (Cell Line: HCC-2998) [3]
Vinflunine + Fulvestrant DC9SE5L Fulvestrant Melanoma (Cell Line: SK-MEL-2) [3]
Vinflunine + Fulvestrant DCC515A Fulvestrant Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Vinflunine + Hepzato DCLOPGX Hepzato Adenocarcinoma (Cell Line: HT29) [3]
Vinflunine + Hepzato DCBFZHO Hepzato Adenocarcinoma (Cell Line: HCT-15) [3]
Vinflunine + Hepzato DC9X6C6 Hepzato High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Ixabepilone DCRBR5Z Ixabepilone High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vinflunine + Ixabepilone DCGD7HX Ixabepilone Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Vinflunine + Dactinomycin DCK4LX4 Dactinomycin Amelanotic melanoma (Cell Line: M14) [3]
Vinflunine + Dactinomycin DC28YXG Dactinomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + PMID28460551-Compound-2 DCYV1ZU PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Vinflunine + Cyclophosphamide DCBI0S0 Cyclophosphamide Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + Methotrexate DCEMGRP Methotrexate Prostate carcinoma (Cell Line: PC-3) [3]
Vinflunine + Isoniazid DC85A4C Isoniazid Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + Arsenic trioxide DCSBIH1 Arsenic trioxide Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinflunine + Arsenic trioxide DC2BYQO Arsenic trioxide Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Vinflunine + Arsenic trioxide DCMOQD1 Arsenic trioxide Malignant melanoma (Cell Line: LOX IMVI) [3]
Vinflunine + Arsenic trioxide DCUFWM1 Arsenic trioxide Melanoma (Cell Line: UACC-257) [3]
Vinflunine + Arsenic trioxide DCBW25Z Arsenic trioxide Melanoma (Cell Line: MALME-3M) [3]
Vinflunine + Plicamycin DCXMK0R Plicamycin Amelanotic melanoma (Cell Line: M14) [3]
Vinflunine + Plicamycin DCM5WVV Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Vinflunine + Nilotinib DC2QYOW Nilotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinflunine + Nilotinib DCDCEHV Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Topetecan DCFFC1Z Topetecan Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + Pralatrexate DCUS54N Pralatrexate Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vinflunine + Pralatrexate DCD3UCV Pralatrexate Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vinflunine + Terameprocol DCMFIL2 Terameprocol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Ifosfamide DCNE9UF Ifosfamide Adenocarcinoma (Cell Line: HCC-2998) [3]
Vinflunine + Ifosfamide DCAEGYJ Ifosfamide Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + Ifosfamide DCLSHFL Ifosfamide Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vinflunine + Ifosfamide DCJ6OAB Ifosfamide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Ifosfamide DCLHZQI Ifosfamide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinflunine + Ifosfamide DC47984 Ifosfamide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vinflunine + Ifosfamide DCFTX5S Ifosfamide Lung adenocarcinoma (Cell Line: EKVX) [3]
Vinflunine + Ifosfamide DCNCAWY Ifosfamide Melanoma (Cell Line: MALME-3M) [3]
Vinflunine + Ifosfamide DC8F3FA Ifosfamide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + Ifosfamide DCGF0J7 Ifosfamide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Vinflunine + Ifosfamide DCQIS4B Ifosfamide Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Vinflunine + Docetaxel DC3J9KR Docetaxel Adenocarcinoma (Cell Line: HT29) [3]
Vinflunine + Docetaxel DCG8R6X Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vinflunine + Docetaxel DCIMFCX Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + Docetaxel DCZJUZ6 Docetaxel Malignant melanoma (Cell Line: UACC62) [3]
Vinflunine + Raloxifene DC9WCTJ Raloxifene Adenocarcinoma (Cell Line: DU-145) [3]
Vinflunine + Raloxifene DCRO588 Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vinflunine + Raloxifene DCAFOJI Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Raloxifene DCL32QO Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vinflunine + Raloxifene DCUMV1Q Raloxifene Malignant melanoma (Cell Line: LOX IMVI) [3]
Vinflunine + Raloxifene DCBY9MG Raloxifene Melanoma (Cell Line: UACC-257) [3]
Vinflunine + Bendamustine hydrochloride DC0J9T2 Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [3]
Vinflunine + Bendamustine hydrochloride DC081Y2 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [3]
Vinflunine + Bendamustine hydrochloride DC6XJNN Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [3]
Vinflunine + Sirolimus DC8RPKY Sirolimus Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinflunine + Sirolimus DCLSE5Q Sirolimus Adenocarcinoma (Cell Line: A549) [3]
Vinflunine + Sirolimus DC23BFF Sirolimus Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vinflunine + Sirolimus DC8Q252 Sirolimus Malignant melanoma (Cell Line: LOX IMVI) [3]
Vinflunine + Sirolimus DC73KYQ Sirolimus Prostate carcinoma (Cell Line: PC-3) [3]
Vinflunine + Mitomycin DCLUW36 Mitomycin Adenocarcinoma (Cell Line: DU-145) [3]
Vinflunine + Mitomycin DCN7FI1 Mitomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Vinflunine + Mitomycin DCO626B Mitomycin Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + Mitomycin DCDW2R5 Mitomycin Adenocarcinoma (Cell Line: HT29) [3]
Vinflunine + Mitomycin DC79GOI Mitomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vinflunine + Mitomycin DC7NFTV Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Mitomycin DCS1S6X Mitomycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinflunine + Mitomycin DCDOL4N Mitomycin Malignant melanoma (Cell Line: UACC62) [3]
Vinflunine + Altretamine DCIDHLS Altretamine Amelanotic melanoma (Cell Line: M14) [3]
Vinflunine + TEM DCL4VPS TEM Adenocarcinoma (Cell Line: A549) [3]
Vinflunine + Bortezomib DC0LM75 Bortezomib Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinflunine + Valrubicin DC5JQA1 Valrubicin Adenocarcinoma (Cell Line: HCT116) [3]
Vinflunine + Valrubicin DCGQKOX Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vinflunine + Valrubicin DC4CQYY Valrubicin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Vinflunine + Valrubicin DCC8EFO Valrubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinflunine + Valrubicin DCSFPFU Valrubicin Prostate carcinoma (Cell Line: PC-3) [3]
Vinflunine + Cisplatin DCR7APJ Cisplatin Adenocarcinoma (Cell Line: HCT116) [3]
Vinflunine + Cisplatin DCIXPBU Cisplatin Malignant melanoma (Cell Line: LOX IMVI) [3]
Vinflunine + Cisplatin DCFFWL4 Cisplatin Malignant melanoma (Cell Line: UACC62) [3]
Vinflunine + Chlorambucil DCC1VOE Chlorambucil Adenocarcinoma (Cell Line: HCT-15) [3]
Vinflunine + ER819762 DCEPR6L ER819762 Adenocarcinoma (Cell Line: A549) [3]
Vinflunine + ER819762 DCSEAPJ ER819762 Adenocarcinoma (Cell Line: HCT-15) [3]
Vinflunine + ER819762 DCYZIUR ER819762 Adenocarcinoma (Cell Line: HCT116) [3]
Vinflunine + ER819762 DC7L9R0 ER819762 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Vinflunine + ER819762 DCNHLIP ER819762 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + ER819762 DCDCBI9 ER819762 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + Romidepsin DCKGDN4 Romidepsin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinflunine + Romidepsin DCMYDPA Romidepsin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinflunine + Azacitidine DC98UEQ Azacitidine Adenocarcinoma (Cell Line: HT29) [3]
Vinflunine + Azacitidine DC471QY Azacitidine Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Vinflunine + Azacitidine DCI85AQ Azacitidine Malignant melanoma (Cell Line: UACC62) [3]
Vinflunine + Azacitidine DCIMY4C Azacitidine Melanoma (Cell Line: MALME-3M) [3]
Vinflunine + Pomalidomide DCIAW2K Pomalidomide Adenocarcinoma (Cell Line: HCC-2998) [3]
Vinflunine + Pomalidomide DCL5ZAZ Pomalidomide Amelanotic melanoma (Cell Line: M14) [3]
Vinflunine + Pomalidomide DCE44I5 Pomalidomide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Vinflunine + Pomalidomide DCO7LGR Pomalidomide Malignant melanoma (Cell Line: UACC62) [3]
Vinflunine + Pomalidomide DCTSLWZ Pomalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Vinflunine + Mepacrine DCGEI7Y Mepacrine Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + Mepacrine DCY1VX7 Mepacrine Adenocarcinoma (Cell Line: HCT116) [3]
Vinflunine + Mepacrine DC8RYEJ Mepacrine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + PMID28870136-Compound-43 DC1EF4G PMID28870136-Compound-43 Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + PMID28870136-Compound-43 DCAN38K PMID28870136-Compound-43 Adenocarcinoma (Cell Line: HCT-15) [3]
Vinflunine + PMID28870136-Compound-43 DCTMRAW PMID28870136-Compound-43 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vinflunine + PMID28870136-Compound-43 DCHLELH PMID28870136-Compound-43 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + PMID28870136-Compound-43 DC0O0ZP PMID28870136-Compound-43 Malignant melanoma (Cell Line: LOX IMVI) [3]
Vinflunine + FORMESTANE DC2UVXV FORMESTANE Adenocarcinoma (Cell Line: DU-145) [3]
Vinflunine + FORMESTANE DCCVVGI FORMESTANE Adenocarcinoma (Cell Line: HCT116) [3]
Vinflunine + FORMESTANE DC9OVKE FORMESTANE Adenocarcinoma (Cell Line: SW-620) [3]
Vinflunine + FORMESTANE DC165LC FORMESTANE High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + FORMESTANE DC5VS0R FORMESTANE Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinflunine + FORMESTANE DCCXHOB FORMESTANE Lung adenocarcinoma (Cell Line: EKVX) [3]
Vinflunine + Aminolevulinic Acid Hydrochloride DCM0FTK Aminolevulinic Acid Hydrochloride Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Vinflunine + Aminolevulinic Acid Hydrochloride DCT3M5R Aminolevulinic Acid Hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Vinflunine + Busulfan DCR558C Busulfan Adenocarcinoma (Cell Line: DU-145) [3]
Vinflunine + Busulfan DC7VHPF Busulfan Adenocarcinoma (Cell Line: HT29) [3]
Vinflunine + Busulfan DCR0R5F Busulfan Malignant melanoma (Cell Line: UACC62) [3]
Vismodegib + Vinflunine DCTDBEH Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [2]
Vismodegib + Vinflunine DCS9AY7 Vismodegib Carcinoma (Cell Line: MCF7) [2]
Vismodegib + Vinflunine DCLJWXW Vismodegib Colon carcinoma (Cell Line: KM12) [2]
Vismodegib + Vinflunine DCI7B8C Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [2]
Vismodegib + Vinflunine DC5C7KL Vismodegib Adenocarcinoma (Cell Line: OVCAR3) [3]
Vismodegib + Vinflunine DCG5KHA Vismodegib Adenocarcinoma (Cell Line: NCIH23) [3]
Vismodegib + Vinflunine DCXYNF4 Vismodegib Adenocarcinoma (Cell Line: HCT-15) [3]
Vismodegib + Vinflunine DCTLRNQ Vismodegib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Vismodegib + Vinflunine DCXMFOS Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Vismodegib + Vinflunine DC2EYA6 Vismodegib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Vismodegib + Vinflunine DC3Y5IP Vismodegib Glioma (Cell Line: SF-539) [3]
Vismodegib + Vinflunine DCZ3NOA Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Vismodegib + Vinflunine DCA83I8 Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Vismodegib + Vinflunine DCB9D5B Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vismodegib + Vinflunine DC59KFM Vismodegib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Vismodegib + Vinflunine DC9TD39 Vismodegib Renal cell carcinoma (Cell Line: SN12C) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 615 DrugCom(s)
6 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Erlotinib + Vinflunine DCB80B5 Erlotinib Unspecified Adult Solid Tumor, Protocol Specific [5]
Gemcitabine + Vinflunine DCOOWI2 Gemcitabine Bladder Cancer [6]
Pemetrexed + Vinflunine DCWR70B Pemetrexed Unspecified Adult Solid Tumor, Protocol Specific [5]
Vinflunine + Capecitabine DCCWW4I Capecitabine Breast Cancer [7]
Gemcitabine + Vinflunine DC7LGYF Gemcitabine Urothelial Carcinoma [8]
Docetaxel + Vinflunine DCP3FIP Docetaxel Urothelial Cancer [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 DrugCom(s)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
3 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
4 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
5 ClinicalTrials.gov (NCT00320073) Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
6 ClinicalTrials.gov (NCT00389155) First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
7 ClinicalTrials.gov (NCT00450515) Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer
8 ClinicalTrials.gov (NCT02665039) A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
9 ClinicalTrials.gov (NCT03390504) A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations